Search Tag: GVHD

Executive Health Management

Latest Drug Reduces Fatal Transplant Side Effect By 50%

2013 04 Dec

According to researchers at the University of Michigan Comprehensive Cancer Center a new class of drugs is capable to reduce patients’ risk of contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments.The innovative study, published in The Lancet Oncology and a first to test this treatment in humans, investigated... Read more


Endorsed Companies